| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |